Tag Archives: Drug

Regeneron Asks F.D.A. for Emergency Approval for Drug That Trump Claimed Cured Him

The drug maker Regeneron said on Wednesday evening that it had submitted an application to the Food and Drug Administration for emergency approval of the experimental antibody cocktail that President Trump had praised just hours earlier without evidence as a “cure” for the coronavirus. The company said that at first, access to the treatment would… Read More »

Accutane Acne Drug Widely ‘Overused’ Says UK Dermatologist

By Dr. Mercola Up to 50 million Americans struggle with acne, making it the most common skin disorder in the United States.1 When it strikes during the teen years, it can lead to feelings of self-consciousness, embarrassment and depression. Many severe acne sufferers struggle with low self-confidence, feelings of alienation and social withdrawal as a… Read More »

Drug company influence on journalism

Many times through the years, HealthNewsReview.org has criticized the National Press Foundation in Washington, DC, for accepting drug company funding for journalism training.  (See articles from June 2009, July 2009, August 2010, September 2010, October 2010, March 2014, March 2015, December 2015, November 2019. I may have missed a few, but you get the picture.) They’re doing it… Read More »

Tremfya (guselkumab) Approved by U.S. Food and Drug Administration as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis

Print this page HORSHAM, PA, July 14, 2020 – The Janssen Pharmaceutical Companies of Johnson & Johnson today announced that the U.S. Food and Drug Administration (FDA) has approved Tremfya (guselkumab) for adult patients with active psoriatic arthritis (PsA), a chronic progressive disease characterized by painful joints and skin inflammation.[1],[2] Tremfya is the first treatment… Read More »